There is an age-old debate about whether a large clinical research organization like Veristat is better than a mid-size one. While the size of the CRO does matter in successful clinical trials, it is not the only factor to look at when choosing a CRO for your trial. Here are some of the reasons why the size of the research organization matters when conducting clinical trials:
Large CROs are better financially positioned to take on the risks of conducting clinical trials for big pharma companies. On the other hand, small pharma must go for multiple bids. Multiple bids will help them choose a CRO that can fit their budget and the quality of services they require.
Large CROs can access large populations since they have the budget. This means they have a chance of more successful patient recruitment due to their reputed names. You will find that most patients prefer to participate in reputed organizations. You will need to understand the patient recruitment capabilities of a small CRO. Understand if they have efficient resources, time, and strategies for successful patient recruitment. Some small CROs are not in a position to recruit patients in certain geographical areas.
Attention to your project
You will often find that big CROs will assign their best teams to big companies while the other teams are not as competent as those assigned to small companies. This often means that small companies will not get the attention they need from the CROs. If you are a small company, you might consider going with a small CRO who will give your project the attention it deserves. You will also find that some companies will assign a project manager in different areas to save on costs.
Global reach is an important factor to consider when choosing a CRO. Large CROs will often handle many regions or have alliances that allow them to have a global reach, while small CROs often lack the capacity for a global reach. Choosing a CRO that lacks the required global reach for your project may increase the overall cost and difficulty in project management. If your study requires a global reach, it is best to use a large CRO. This way, you will ensure a smooth and cost-efficient trial.
Evaluating the previous experience is vital before your partner with any CRO. It is more important when participating in rare disease clinical trials where your patient recruitment might be challenging. Many small companies and start-ups are working on choosing the best CRO for their clinical trials, which might be challenging. Evaluating the CROs’ experience in the area you want to conduct a clinical trial is important. Large and small CROs have different strengths in terms of experience in different areas. Choose the CRO that matches your specific needs regardless of size. This way, you will be able to get the best services from the most experienced.
While the size of the CRO might not matter depending on the type of clinical trial you are conducting, it is important to always ensure that you choose one that fully matches your needs. It would help if you considered some factors, including cost, global reach, and the CROs experience.